Nexus Neurotech

Nobi is a smart lamp that ensures help can be provided in a flash in the event of a fall. It recognizes a fall, and it will notify a family member, contacts, or a specialized emergency call center. The lamp will then connect to that person to reassure them that help is on the way. If necessary, it can even unlock the smart lock on the front door.

Cala Health, Inc. is a bioelectronic medicine company based in Burlingame, California, founded in 2013. The company specializes in developing wearable neuromodulation therapies aimed at treating chronic diseases. Its flagship product, Cala Trio, is a non-invasive prescription therapy designed to provide transient relief from hand tremors in adults with essential tremor. By integrating advancements in neuroscience and technology, Cala Health focuses on individualized peripheral nerve stimulation to enhance patient outcomes. In addition to its work on essential tremor, the company is also developing therapies for conditions such as Parkinson's disease, as well as exploring applications in psychiatry, cardiology, and autoimmune disorders.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Synapticure is a virtual clinical care platform dedicated to supporting patients with neurodegenerative diseases, including dementia, Parkinson's, and ALS, across the United States. Founded by individuals with personal experiences in these conditions, the company offers a comprehensive suite of services that includes access to specialized neurologists, speech-language therapy, and 24/7 care coordination. Synapticure leverages advances in science and technology to ensure patients receive tailored treatment and support, fostering a holistic approach to care. By integrating various healthcare services, the platform simplifies access to essential medical resources, including behavioral health support, all designed to enhance the quality of life for those affected by neurodegenerative disorders.

EarliTec Diagnostics is a digital health company focused on the early identification and treatment of autism spectrum disorder (ASD) and related disabilities in children. Developed by researchers from Children's Healthcare of Atlanta, Emory University School of Medicine, and Yale University, the company is at the forefront of creating biomarkers that enhance understanding of children's perspectives. EarliTec's innovative technology includes an investigational device that employs dynamic quantification of social-visual engagement (DQSVE) to analyze subtle looking behaviors that are often unnoticed by the naked eye. This advanced approach enables parents, healthcare providers, and caregivers to deliver personalized and timely therapeutic interventions tailored to individual needs.

Rune Labs, Inc. is a technology company that offers a software-as-a-service platform designed to support neuromodulation systems in managing complex therapies. Established in 2018 and headquartered in San Francisco, California, the platform integrates brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. Rune Labs primarily serves pharmaceutical and med-tech companies, assisting them in developing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The platform provides a secure, cloud-based infrastructure that enables clients to efficiently analyze large volumes of brain data, facilitating the implementation of sophisticated therapy algorithms and enhancing the precision of medicine delivered to patients.